VanEck Vectors Pharmaceutical ETF (PPH): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
PPH Stock Price Chart Interactive Chart >
PPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $74.59 | 52-week high | $84.27 |
Prev. close | $75.56 | 52-week low | $66.59 |
Day low | $74.59 | Volume | 94,000 |
Day high | $75.67 | Avg. volume | 174,804 |
50-day MA | $77.03 | Dividend yield | 1.59% |
200-day MA | $74.87 |
VanEck Vectors Pharmaceutical ETF (PPH) ETF Bio
The investment objective of the Market Vectors Pharmaceutical ETF seeks to replicate as closely as possible the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index.
PPH ETF Info
Issuer | Van Eck Associates |
Expense Ratio | 0.35% |
Underlying Index | MVIS US Listed Pharmaceutical 25 Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 487.82M |
Net Asset Value (NAV) | $74.59 |
Options? | Yes |
Total Holdings | 28 |
PPH Top Holdings
Symbol | Company | % of Total |
MCK | Mckesson Corp | 5.45% |
AZN | Astrazeneca Plc | 5.33% |
MRK | Merck & Co Inc | 5.28% |
LLY | Eli Lilly & Co | 5.24% |
BMY | Bristol-Myers Squibb Co | 5.08% |
NVS | Novartis Ag | 5.06% |
TEVA | Teva Pharmaceutical Industries Ltd | 4.96% |
ABBV | Abbvie Inc | 4.92% |
JNJ | Johnson & Johnson | 4.91% |
TAK | Takeda Pharmaceutical Co Ltd | 4.89% |
PPH Price Returns
1-mo | -4.00% |
3-mo | -4.41% |
6-mo | 10.90% |
1-year | -3.63% |
3-year | 65.19% |
5-year | 47.27% |
YTD | -4.05% |
2022 | 2.64% |
2021 | 17.79% |
2020 | 5.48% |
2019 | 19.39% |
2018 | -5.89% |
PPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |